425 related articles for article (PubMed ID: 29055182)
1. Computational drug repositioning for rare diseases in the era of precision medicine.
Delavan B; Roberts R; Huang R; Bao W; Tong W; Liu Z
Drug Discov Today; 2018 Feb; 23(2):382-394. PubMed ID: 29055182
[TBL] [Abstract][Full Text] [Related]
2. Computational and experimental advances in drug repositioning for accelerated therapeutic stratification.
Shameer K; Readhead B; Dudley JT
Curr Top Med Chem; 2015; 15(1):5-20. PubMed ID: 25579574
[TBL] [Abstract][Full Text] [Related]
3. Drug target gene-based analyses of drug repositionability in rare and intractable diseases.
Sakate R; Kimura T
Sci Rep; 2021 Jun; 11(1):12338. PubMed ID: 34117295
[TBL] [Abstract][Full Text] [Related]
4. A survey of current trends in computational drug repositioning.
Li J; Zheng S; Chen B; Butte AJ; Swamidass SJ; Lu Z
Brief Bioinform; 2016 Jan; 17(1):2-12. PubMed ID: 25832646
[TBL] [Abstract][Full Text] [Related]
5. eRepo-ORP: Exploring the Opportunity Space to Combat Orphan Diseases with Existing Drugs.
Brylinski M; Naderi M; Govindaraj RG; Lemoine J
J Mol Biol; 2018 Jul; 430(15):2266-2273. PubMed ID: 29237557
[TBL] [Abstract][Full Text] [Related]
6. Rare diseases and omics-driven personalized medicine.
Šimić G
Croat Med J; 2019 Dec; 60(6):485-487. PubMed ID: 31894912
[No Abstract] [Full Text] [Related]
7. Network-Based Drug Repositioning: Approaches, Resources, and Research Directions.
Alaimo S; Pulvirenti A
Methods Mol Biol; 2019; 1903():97-113. PubMed ID: 30547438
[TBL] [Abstract][Full Text] [Related]
8. Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.
Cheng F; Hong H; Yang S; Wei Y
Brief Bioinform; 2017 Jul; 18(4):682-697. PubMed ID: 27296652
[TBL] [Abstract][Full Text] [Related]
9. MD-Miner: a network-based approach for personalized drug repositioning.
Wu H; Miller E; Wijegunawardana D; Regan K; Payne PRO; Li F
BMC Syst Biol; 2017 Oct; 11(Suppl 5):86. PubMed ID: 28984195
[TBL] [Abstract][Full Text] [Related]
10. Drug development in the era of precision medicine.
Dugger SA; Platt A; Goldstein DB
Nat Rev Drug Discov; 2018 Mar; 17(3):183-196. PubMed ID: 29217837
[TBL] [Abstract][Full Text] [Related]
11. Integrative methods for analyzing big data in precision medicine.
Gligorijević V; Malod-Dognin N; Pržulj N
Proteomics; 2016 Mar; 16(5):741-58. PubMed ID: 26677817
[TBL] [Abstract][Full Text] [Related]
12. Uncovering novel repositioning opportunities using the Open Targets platform.
Khaladkar M; Koscielny G; Hasan S; Agarwal P; Dunham I; Rajpal D; Sanseau P
Drug Discov Today; 2017 Dec; 22(12):1800-1807. PubMed ID: 28919242
[TBL] [Abstract][Full Text] [Related]
13. Potential Reuse of Oncology Drugs in the Treatment of Rare Diseases.
Liu Z; Fang H; Slikker W; Tong W
Trends Pharmacol Sci; 2016 Oct; 37(10):843-857. PubMed ID: 27461952
[TBL] [Abstract][Full Text] [Related]
14. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
Koromina M; Pandi MT; Patrinos GP
OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
[TBL] [Abstract][Full Text] [Related]
15. Development of precision therapies for rare inborn errors of metabolism: Functional investigations in cell culture models.
Didiasova M; Banning A; Tikkanen R
J Inherit Metab Dis; 2024 May; 47(3):509-516. PubMed ID: 37606592
[TBL] [Abstract][Full Text] [Related]
16. Rare Diseases: Drug Discovery and Informatics Resource.
Zhao M; Wei DQ
Interdiscip Sci; 2018 Mar; 10(1):195-204. PubMed ID: 29094320
[TBL] [Abstract][Full Text] [Related]
17. Drug repositioning for rare diseases: Knowledge-based success stories.
Scherman D; Fetro C
Therapie; 2020 Apr; 75(2):161-167. PubMed ID: 32164975
[TBL] [Abstract][Full Text] [Related]
18. Old friends in new guise: repositioning of known drugs with structural bioinformatics.
Haupt VJ; Schroeder M
Brief Bioinform; 2011 Jul; 12(4):312-26. PubMed ID: 21441562
[TBL] [Abstract][Full Text] [Related]
19. Repositioning Drugs for Rare Immune Diseases: Hopes and Challenges for a Precision Medicine.
Valencic E; Smid A; Jakopin Z; Tommasini A; Mlinaric-Rascan I
Curr Med Chem; 2018; 25(24):2764-2782. PubMed ID: 28875839
[TBL] [Abstract][Full Text] [Related]
20. Drug repositioning by integrating target information through a heterogeneous network model.
Wang W; Yang S; Zhang X; Li J
Bioinformatics; 2014 Oct; 30(20):2923-30. PubMed ID: 24974205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
